CHRS Stock

Value Stocks

Coherus Oncology Inc (NASDAQ:CHRS) gain 10.46% – Is It right time to buy?

Colin Adrian

Coherus Oncology Inc (CHRS) saw an uptrend of 10.46% in the recent trading with $1.69 being its most recent. The ...

Business

What Are Analyst Opinions Regarding Coherus Oncology Inc (CHRS)?

Cody Benson

Coherus Oncology Inc (CHRS) saw an uptrend of 5.15% in the recent trading with $1.43 being its most recent. The ...

Value Stocks

Coherus Oncology Inc (CHRS): The long term indicators on the stock call for a Buy today

Heidi Phillips

Coherus Oncology Inc (CHRS) saw an uptrend of 5.22% in the recent trading with $1.41 being its most recent. The ...

Business

Coherus Oncology Inc (CHRS): The stock medium term indicators say Buy today

Cody Benson

Coherus Oncology Inc (CHRS) saw an uptrend of 1.52% in the recent trading with $1.34 being its most recent. The ...

Baxter Report
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.